Search Results - "Redondo Sanchez, A."

Employment in a cohort of breast cancer patients by Molina Villaverde, R., Feliu Batlle, J., Villalba Yllan, A., Jiménez Gordo, A. M., Redondo Sánchez, A., San Jose Valiente, B., Gonzalez Baron, M.

“…Background Breast cancer survivors can have problems in returning to work. However, the importance of work to cancer survivors has until recently received…”
Get full text

Nasal septum perforation in a breast cancer patient treated with bevacizumab by Marín, Á. Pinto, Sánchez, A. Redondo, Arranz, E. Espinosa

Get full text

556 Effect of One Step Molecular Intraoperative Method in Detection of Micrometastasis in Sentinel Node and Management of Them by Sanchez-Mendez, J, Lopez-Rodriguez, M.J, Escabias Del Pozo, C, Oliver Goldaracena, J.M, Redondo Sanchez, A, Belinchon Olmeda, B, Hardisson Hernaez, D

Get full text

[Translated article] Oligometastases in oncological orthopaedic surgery. Our experience by Ortiz-Cruz, E.J., García-Mauriño Peñín, C., Moriel-Garceso, D.J., Peleteiro Pensado, M., Barrientos Ruiz, I., Redondo Sánchez, A., Pozo-Kreilinger, J.J., Belinchón-Olmeda, B., Tapia-Viñe, M.

“…To analyse the incidence and survival of patients with oligometastases (solitary and normal) when they are treated in centres that are experts in…”
Get full text

1489MO A phase Ib/II study of selinexor as single agent and in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST): SeliGIST/GEIS-41 trial by Serrano, C., Valverde Morales, C.M., Cruz Jurado, J., Martinez Trufero, J., Martinez-Garcia, J., Roche, S., Redondo Sanchez, A., Giuppi, M., Suarez, B., Romagosa, C., Martinez, V.

Get full text

585P Trabectedin induces apoptosis regardless of acquired resistance to PARP inhibitors in BRCA2 mutant high grade ovarian cancer cell lines by Perez Fidalgo, J.A., Sanchez-Serrano, P., Heredia, V., Martinez Pretel, J.J., Hochstadt, J., Mendiola, M., Redondo Sanchez, A., Burgués, O., Pineda Merlo, B.

Get full text

741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion by Pothuri, B., Naumann, R.W., Martin, L.P., O'Malley, D., Uyar, D., Moroney, J.W., Diaz, J., Garcia-Donas, J., Redondo Sanchez, A., Gonzalez Martin, A., Illescas, D.G., Liu, L., Berman, C., Oaknin, A.

Get full text

530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety by Gonzalez Martin, A.J., Pothuri, B., Vergote, I.B., Graybill, W., Mirza, M.R., Mccormick, C., Lorusso, D., Freyer, G., Backes, F., Baumann, K.H., Redondo Sanchez, A., Moore, R.G., Vulsteke, C., O'Cearbhaill, R.E., Malinowska, I., Shtessel, L., Compton, N., Monk, B.J.

Get full text

583P Aurora kinase overexpression may play a role in PARPi resistance in tumor samples of patients with high grade ovarian cancer and its inhibition with alisertib overcomes resistance to olaparib in a PARPi-resistant cell line model by Perez Fidalgo, J.A., Martinez Pretel, J.J., Heredia, V., Romeo Marin, M., Mendiola, M., Hochstadt, J., Bernat, A., Sanchez-Serrano, P., Redondo Sanchez, A., Gil Martín, M., Guerra Ojeda, S., Teruel, I., Burgués, O., Cervantes, A., Pineda Merlo, B.

Get full text

1926P Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients: Results from the SYNERGIAS study - A Spanish group for research in sarcoma (GEIS) phase II study by Martin-Broto, J., Kopeckova, K., Azinovic, I., Jurado, J. Cruz, Guzmán, L., Alvarez, R.M., Herraez, A. Casado, Morales, C.M. Valverde, Sanchez, A. Redondo, Lleida, R. Teres, Gonzalez, A. Alvarez, Dolado, M.C., Doval, A., Belinchón, B., Merino, J.A., Mendez, R., Ledesma, P., Gutierrez, A., Da Silva Moura, D., Hindi Muñiz, N.

Get full text

134P Doxorubicin and olaparib (OLA) synergism in high-grade serous ovarian (HGOC) and triple-negative breast cancer (TNBC) cell lines with olaparib-resistance by Fidalgo, J.A. Perez, Pretel, J.J. Martinez, Sanchez-Serrano, P., Heredia, V., Mendiola, M., Sanchez, A. Redondo, Burgues, O., Merlo, B. Pineda

Get full text

33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional PFS by Gonzalez Martin, A.J., Pothuri, B., Vergote, I.B., Graybill, W., Mirza, M.R., McCormick, C., Lorusso, D., Freyer, G., Backes, F., Heitz, F., Redondo Sanchez, A., Moore, R., Vulsteke, C., O'Cearbhaill, R.E., Malinowska, I., Shtessel, L., York, W., Monk, B.J.

Get full text

Síndrome de burnout en profesionales sanitarios de Cuidados Paliativos de la Comunidad de Madrid by SANTAMARIA GRACIA, E. M, RODRIGUEZ-SALVANES, F, GONZALEZ-GONZALEZ, R, FERNANDEZ LUQUE, M. J, REDONDO SANCHEZ, A

Get full text

Derrame pleural masivo como primera manifestación de pancreatitis crónica by Linares Torres, P., Redondo Sánchez, A., Molina Villaverde, R.

Get full text

Primary intestinal T lymphoma: a report of two cases and a review of the literature by Molina Villaverde, R, Jiménez Gordo, A, López González, J L, Redondo Sánchez, A, Andreu Rodríguez, M, González Barón, M

“…Lymphomas of the gastrointestinal tract are the most common type of primary extranodal lymphomas and about 15-20% of these are primary intestinal lymphomas…”
Get full text

Linfoma T primario intestinal: a propósito de dos casos con revisión de la literatura by Molina Villaverde, R, Jiménez Gordo, A., López González, J. L., Redondo Sánchez, A., Andreu Rodríguez, M., González Barón, M.

Get full text

Massive pleural effusion as the first manifestation of chronic pancreatitis by Linares Torres, P, Redondo Sánchez, A, Molina Villaverde, M

Get full text

Linfoma T primario intestinal: a propósito de dos casos con revisión de la literatura by Molina Villaverde, Jiménez Gordo, A., López González, J. L., Redondo Sánchez, A., Andreu Rodríguez, M., González Barón, M.

“…Los linfomas del tracto gastrointestinal son el tipo más frecuente de linfomas extraganglionares y de éstos el 15-20% son de localización intestinal. Pueden…”
Get full text